HIP
IPXL

Hatteras Investment Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Hatteras Investment Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-41,141
Closed -$1.93M – 149
2015
Q1 		$1.93M Buy
+41,141
New +$1.64M 1.03% 31

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Hatteras Investment Partners's IPXL Position: Q2 2015 in Review

Hatteras Investment Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 41,141 shares — an estimated $1.93M sold.

Hatteras Investment Partners first reported a position in IPXL in Q1 2015 and held it in 1 quarter. The position peaked at $1.93M in Q1 2015. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

  • Hatteras Investment Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
  • Hatteras Investment Partners sold 41,141 Impax Laboratories, Inc. shares in Q2 2015, an estimated $1.93M.
  • Hatteras Investment Partners first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 1 quarter.
  • Hatteras Investment Partners's Impax Laboratories, Inc. position peaked at $1.93M in Q1 2015.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on Hatteras Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.